| Bioactivity | Trazium esilate (EGYT-3615) is an antidepressant, which influences the central dopaminergic system. Trazium esilate synergizes amphetamine, potentiates stereotypy and hypermotility. Trazium esilate blocks Apomorphine (HY-12723)-induced hypothermic and the stereotypy, and Bulbocapnine (HY-W436270)-induced cataleptic state. Trazium esilate enhances the effect of Norepinephrine (HY-13715) on isolated vas deferens of the rat[1]. |
| CAS | 97110-59-3 |
| Formula | C19H18ClN3O4S |
| Molar Mass | 419.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gyertyán I, et al., Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate. Arzneimittelforschung. 1989 Jul;39(7):775-81. |
Trazium esilate
CAS: 97110-59-3 F: C19H18ClN3O4S W: 419.88
Trazium esilate (EGYT-3615) is an antidepressant, which influences the central dopaminergic system. Trazium esilate syne
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.